DWJ 209Alternative Names: DWJ209
Latest Information Update: 21 Jan 2015
At a glance
- Originator Daewoong Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Lung cancer; Pancreatic cancer
Most Recent Events
- 21 Jan 2015 Early research in Pancreatic cancer in South Korea (unspecified route)
- 21 Jan 2015 Early research in Lung cancer in South Korea (unspecified route)